|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0023981,
umls-concept:C0034656,
umls-concept:C0083701,
umls-concept:C0332281,
umls-concept:C0681867,
umls-concept:C0729866,
umls-concept:C0771774,
umls-concept:C1457887,
umls-concept:C1514811,
umls-concept:C1561577,
umls-concept:C1698986,
umls-concept:C1704272,
umls-concept:C1706462
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2009-1-5
|
|
pubmed:abstractText |
In order to compare the clinical efficacy of naftopidil (Naf) and tamsulosin hydrochloride (Tam), which differ in their selectivity to alpha receptor subtypes, we performed a multi-center prospective randomized controlled study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1442-2042
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1049-54
|
|
pubmed:meshHeading |
pubmed-meshheading:19120513-Adrenergic alpha-Antagonists,
pubmed-meshheading:19120513-Aged,
pubmed-meshheading:19120513-Humans,
pubmed-meshheading:19120513-Male,
pubmed-meshheading:19120513-Middle Aged,
pubmed-meshheading:19120513-Naphthalenes,
pubmed-meshheading:19120513-Piperazines,
pubmed-meshheading:19120513-Prospective Studies,
pubmed-meshheading:19120513-Prostatic Hyperplasia,
pubmed-meshheading:19120513-Sulfonamides,
pubmed-meshheading:19120513-Urination Disorders
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia with special reference to the storage symptom: a prospective randomized controlled study.
|
|
pubmed:affiliation |
Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan. ukimura@koto.kpu-m.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
